Free Trial

Talis Biomedical Q3 2023 Earnings Report

Talis Biomedical logo
$1.73 -0.11 (-6.11%)
(As of 12/20/2024 04:19 PM ET)

Talis Biomedical EPS Results

Actual EPS
-$8.62
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Talis Biomedical Revenue Results

Actual Revenue
$0.14 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Talis Biomedical Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Talis Biomedical Earnings Headlines

Talis Biomedical Corp Ordinary Shares
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
See More Talis Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Talis Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Talis Biomedical and other key companies, straight to your email.

About Talis Biomedical

Talis Biomedical (NASDAQ:TLIS) operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

View Talis Biomedical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings